Summary
This study investigated the effect of cadmium on the telomerase activity, the expression of TERT, c-myc and p53 and the apoptosis of rat hepatocytes. The rats were administrated 5, 10 and 20 μmol/kg cadmium chloride intraperitoneally and sacrificed 48 h after the initial treatment. The telomerase activity of the rat hepatocytes was measured by the telomeric repeat amplification protocol (TRAP), and apoptosis was detected by flow cytometry. The mRNA expressions of TERT, c-myc and p53 were measured by reverse transcription-polymerase chain reaction (RT-PCR). C-myc and P53 proteins were determined by immunochemistry. The results showed that cadmium chloride increased the hepatocellular telomerase activity in a dose-dependant manner and induced the apoptosis of hepatocytes significantly. The value of relative coefficient between the telomerase activity and the apoptosis rate was 0.9398. RT-PCR revealed that specific bands corresponding to the TERT mRNA, c-myc mRNA, and p53 mRNA were displayed at 185, 342 and 538 bp respectively. Cadmium chloride could substantially increase the mRNA expressions of TERT, c-myc and p53 in rat hepatocytes, as compared with control. Moreover, cadmium chloride at the doses of 5, 10 and 20 μmol/kg could increase the content of P53 protein in rat hepatocytes obviously, but only that at the doses of 10 and 20 μmol/kg substantially promoted the c-myc protein level in rat hepatocytes. Our study herein suggested that cadmium may contribute to the carcinogenesis by activating telomerase, and overexpressing the mRNAs of TERT, c-myc and p53, and causing apoptosis of normal cells.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Hahn WC, Stewart SA, Brooks MW, et al. Inhibition of telomerase limits the growth of human cancer cells. Nat Med, 1999,5(10):1164–1170
Shay JW, Wright WE. Telomerase therapeutics for cancer, challenges and new directions. Nat Rev Drug Discov, 2006,5(7):577–584
Yan P, Coindre JM, Benhattar J, et al. Telomerase activity and human telomerase reverse transcriptase mRNA expression in soft tissue tumors: correlation with grade, histology, and proliferative activity. Cancer Res, 1999,59(13):3166–3170
Waalkes MP. Cadmium carcinogenesis. Mutat Res, 2003, 533(1–2):107–120
Waisberg M, Joseph P, Hale B, et al. Molecular and cellular mechanisms of cadmium carcinogenesis. Toxicology, 2003,192(2–3):95–117
Alfonso-De Matte MY, Moses-Soto H, Kruk PA. Calcium-mediated telomerase activity in ovarian epithelial cells. Arch Biochem Biophys, 2002,399(2):239–244
Martínez-Campa CM, Alonso-González C, Mediavilla MD, et al. Melatonin down-regulates hTERT expression induced by either natural estrogens (17beta-estradiol) or metalloestrogens (cadmium) in MCF-7 human breast cancer cells. Cancer Lett, 2008,268(2):272–277
Shin JS, Hong A, Solomon MJ, et al. The role of telomeres and telomerase in the pathology of human cancer and aging. Pathology, 2006,38(2):103–113
Artandi SE. Complex roles for telomeres and telomerase in breast carcinogenesis. Breast Cancer Res, 2003,5(1): 37–41
Krupp G, Klapper W, Parwaresch R. Cell proliferation, carcinogenesis and diverse mechanisms of telomerase regulation. Cell Mol Life Sci, 2000,57(3):464–486
Luzar B, Poljak M, Marin IJ, et al. Telomerase reactivation is an early event in laryngeal carcinogenesis. Mod Pathol, 2003,16(9):841–848
Youssef N, Paradis V, Ferlicot S, et al. In situ detection of telomerase enzymatic activity in human hepatocellular carcinogenesis. J Pathol, 2001,194(4):459–465
Miura N, Horikawa I, Nishimoto A, et al. Progressive telomere shortening and telomerase reactivation during hepatocellular carcinogenesis. Cancer Genet Cytogenet, 1997,93(1):56–62
Kirkpatrick KL, Mokbel K. The significance of human telomerase reverse transcriptase (hTERT) in cancer. Eur J Surg Oncol, 2001,27(8):754–760
Poole JC, Andrews LG, Tollefsbol TO. Activity, function, and gene regulation of the catalytic subunit of telomerase (hTERT). Gene, 2001,269(1–2):1–12
Chen HJ, Yu RA, He LF, et al. Inhibitory effects of selenium on telomerase activity and hTERT expression in cadmium-transformed 16HBE cells. Biomed Environ Sci, 2007,20(4):307–312
Hiyama T, Yokozaki H, Kitadai Y, et al. Overexpression of human telomerase RNA is an early event in oesophageal carcinogenesis. Virchows Arch, 1999,434(6):483–487
Kuniyasu H, Domen T, Hamamoto T, et al. Expression of human telomerase RNA is an early event of stomach carcinogenesis. Jpn J Cancer Res, 1997,88(2):103–107
Cerni C. Telomeres, telomerase, and myc. An update. Mutat Res, 2000,462(1):31–47
Sagawa Y, Nishi H, Isaka K, et al. The correlation of TERT expression with c-myc expression in cervical cancer. Cancer Lett, 2001 168(1):45–50
Wu KJ, Grandori C, Amacker M, et al. Direct activation of TERT transcription by c-MYC. Nat Genet, 1999,21(2): 220–224
Liu YC, Chen CJ, Wu HS, et al. Telomerase and c-myc expression in hepatocellular carcinomas. Eur J Surg Oncol, 2004,30(4):384–390
Dong Y, Li T, Wang Y, et al. Expression of human telomerase reverse transcriptase and c-myc transcripts in endometrial carcinoma and its precursors. Zhonghua Bing Li Xue Za Zhi (Chinese), 2004,33(1):40–43
Yu RA, He LF, Chen XM. Effects of cadmium on hepatocellular DNA damage, proto-oncogene expression and apoptosis in rats. Biomed Environ Sci, 2007,20(2): 146–153
Rahman R, Latonen L, Wiman KG. hTERT antagonizes p53-induced apoptosis independently of telomerase activity. Oncogene, 2005,24(8):1320–1327
Beliveau A, Yaswen P. Soothing the watchman, telomerase reduces the p53-dependent cellular stress response. Cell Cycle, 2007, 6(11):1284–1287
Wisman GB, Hollema H, Helder MN, et al. Telomerase in relation to expression of p53, c-Myc and estrogen receptor in ovarian tumours. Int J Oncol, 2003,23(5):1451–1459
Maniwa Y, Yoshimura M, Obayashi C, et al. Association of p53 gene mutation and telomerase activity in resectable non-small cell lung cancer. Chest, 2001,120(2):589–594
Achanzar WE, Achanzar KB, Lewis J G, et al. Cadmium induces c-Myc, p53, and c-jun expression in normal human prostate epithelial cells as a prelude to apoptosis. Toxicol Appl Pharmacol, 2000,164(3):291–300
Kobayashi T, Sugawara Y, Shi YZ, et al. Telomerase expression and p53 status in hepatocellular carcinoma. Am J Gastroenterol, 2002,97(12):3166–3171
Lasfer M, Vadrot N, Aoudjehane L, et al. Cadmium induces mitochondria-dependent apoptosis of normal human hepatocytes. Cell Biol Toxicol, 2008,24(1):55–62
Bermudez Y, Erasso D, Johnson NC, et al. Telomerase confers resistance to caspase-mediated apoptosis. Clin Interv Aging, 2006,1(2):155–167
Chakraborty S, Ghosh U, Bhattacharyya NP, et al. Inhibition of telomerase activity and induction of apoptosis by curcumin in K-562 cells. Mutat Res, 2006,596(1–2):81–90
Xi L, Chen G, Zhou J, et al. Inhibition of telomerase enhances apoptosis induced by sodium butyrate via mitochondrial pathway. Apoptosis, 2006,11(5):789–798
Mondello C, Scovassi AI. Telomeres, telomerase, and apoptosis. Biochem Cell Biol, 2004,82(4):498–507
Vazquez A, Bond EE, Levine AJ, et al. The genetics of the p53 pathway, apoptosis and cancer therapy. Nat Rev Drug Discov, 2008,7(12):979–987
Author information
Authors and Affiliations
Additional information
This project was supported by the National Natural Sciences Foundation of China (No. 30271110), Scientific Foundation (No. 2006GGW01) and Teacher’s Foundation of Guangdong Pharmaceutical University, China.
Rights and permissions
About this article
Cite this article
Dai, W., Chen, H., Yu, R. et al. Effects of cadmium on telomerase activity, expressions of TERT, c-myc and P53, and apoptosis of rat hepatocytes. J. Huazhong Univ. Sci. Technol. [Med. Sci.] 30, 709–713 (2010). https://doi.org/10.1007/s11596-010-0645-8
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11596-010-0645-8